IPSEN reviews

4.2

86% would recommend to a friend

(662 total reviews)
avatar

David Loew

89% approve of CEO

81% positive business outlook

IPSEN has an employee rating of 4.2 out of 5 stars, based on 662 company reviews on Glassdoor which indicates that most employees have an excellent working experience there. The IPSEN employee rating is in line with the average (within 1 standard deviation) for employers within the Pharmaceutical & Biotechnology industry (3.5 stars).

Reviews by job title

662 reviews
1.0
Nov 18, 2022

Loads of potential......but get getting worse

Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

There is some great vision from David as the CEO and some genuine patient-centricity that isn't present in other companies but.......

Cons

There is deep inequality; ”Face-fitters" and "average yes men" get promoted leading to mediocre performance. We talk about integration yet buy companies with no interest in actually learning what made them good in the first place (and trying to incorporate it!). Business Development..... Do lots of deals but to hell with the reality of that deal and the (lack of) opportunity it brings. There are no processes, no collaboration........ The company runs on the goodwill of a few (and will burn them out until they either don't care or are spent). Employees aren't held to account.

avatar
IPSEN Response
3y
Thank you for taking the time to share your experience – we take your feedback seriously. All employees deserve great leaders, and we expect our managers to inspire and support their teams. Your input helps us create a better workplace for our employees, and we will pass this information along to our team.
1.0
Nov 17, 2022

Run Don't Walk...Away

Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

Pretty sure there are none

Cons

Watching us go through the "supposed" integration with a recently purchased company, it's clear that Paulson leaving didn't help. The US group is beholden to the global team and is ruled by fear. Decisions are rare and churn is eternal. Legacy Ipsen held in limbo for months, employees from Epizyme cut out of the mix. Oncology business unit is a mess - both commercial and medical. This isn't the Ipsen anyone who knows what the original Ipsen was, and it's a shame on so many levels.

avatar
IPSEN Response
3y
Thank you for taking the time to share your experience – we take your feedback seriously. All employees deserve great leaders, and we expect our managers to inspire and support their teams. Your input helps us create a better workplace for our employees, and we will pass this information along to our team.
3.0
Nov 9, 2022
Recommend
CEO approval
Business Outlook

Pros

Shift pattern and No weekends

Cons

Process equipment constantly breaking down and nothing getting done. Too many pointless 'meetings'. Lots of talking but not enough action. Using whiteboards and big sheets of paper for trackers. Way way behind other pharma companies in terms of digitalisation. Training is subpar. Technologists who haven't completed their own training are left to train new hires

avatar
IPSEN Response
3y
Thank you for your review. Your input helps us create a better workplace for our employees, and we appreciate you sharing your feedback. We wish you success in your career.
Viewing 265 - 267 of 662 Reviews

Glassdoor has 1,263 IPSEN reviews submitted anonymously by IPSEN employees. Read employee reviews and ratings on Glassdoor to decide if IPSEN is right for you.